Novel Affinity Purification Methods for Next-Generation Antibodies
Ensuring the integrity, purity and production efficiency of next-generation antibodies is critical in therapeutic and diagnostic applications. However, purification workflows remain challenged by complex assemblies, low expression levels and heterogeneity of products.
High-fidelity affinity chromatography ligands can support more efficient, cost-effective manufacturing, enabling exceptional yield in a single purification step and helping accelerating drugs to market.
This article explores the rapid implementation of novel affinity purification methods for commercial-scale antibody production.
Download this article to learn more about:
- Novel antibody modalities and purification challenges
- Current manufacturing processes and adherence to GMP guidelines
- High-affinity resins suitable for the purification of multiple antibody types
cited from Bioprocess International, October 2019